Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  iproplatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 38 for your search:
Start Over
Phase II/III Comparison of the Platinum Compounds CBDCA vs CHIP vs CACP for Recurrent or Metastatic Epidermoid Carcinoma of the Head and Neck
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8223
Phase III Randomized Comparison of Combination Chemotherapy with CBDCA/CTX vs CACP/CTX in Patients with Stage III/IV Ovarian Carcinoma
Phase: Phase III, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8412
Phase I/II Intraperitoneal Chemotherapy with CHIP in Patients with Intra-Abdominal Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 80
Sponsor: NCI
Protocol IDs: CHNMC-IRB-5141, NCI-T85-0105D, T85-0105
Phase I/II Intraperitoneal Chemotherapy with CHIP in Patients with Intra-Abdominal Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 80
Sponsor:
Protocol IDs: NCOG-P-5O851, NCOG-P-5O-85-1
Phase II Randomized Chemotherapy with CBDCA vs CHIP for Locally Advanced, Recurrent, or Metastatic Squamous Cell Carcinoma of the Cervix
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-77
Phase II Chemotherapy with Platinum IV vs Carboplatin for Advanced Transitional Cell Carcinoma of the Urothelium
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4883, SEG-INT-GU-202
Phase II CBDCA vs CHIP for Advanced or Recurrent Squamous Cell Cancer of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8371
Phase II Chemotherapy with CBDCA vs CHIP in Patients with Bronchogenic Carcinoma of All Cell Types
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-83208
Phase II Chemotherapy with CHIP in Patients with Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: MSKCC-84113, NCI-T84-0476D, T84-0476
Phase II Chemotherapy with CHIP in Men with Refractory Germ Cell Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-207
Phase II Master Protocol Chemotherapy for Advanced or Recurrent Carcinoma of the Breast --- CHIP
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: CLB-8442, CALGB-8442
Phase II Chemotherapy with CHIP vs CBDCA for Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16832B
Phase II Chemotherapy with CHIP for Advanced Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-16834A
Phase II Chemotherapy with CHIP for Advanced Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-16834C
Phase II Chemotherapy with CHIP for Advanced Multiple Myeloma (Summary Last Modified 09/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMC-1674, NCI-T83-1415W, T83-1415
Phase II Chemotherapy with CHIP in Patients with Advanced Gynecologic Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-725, NCI-V85-0099
Phase II Chemotherapy with CHIP in Adult Patients with Recurrent Head and Neck Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-731, NCI-V85-0097
Phase II Chemotherapy with CHIP in Patients with Hormonally Refractory Stage D Carcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UKMC-IRB-30295, NCI-T85-0026R, T85-0026
Phase II Chemotherapy with CHIP in Adult Patients with Genitourinary Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-727, NCI-V85-0098
Phase II Combination Chemotherapy with CHIP/VP-16 in Patients with Cancers of the Lung, Testis, Liver, Stomach, Biliary Tree, and Pancreas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-PPC-829, NCI-V85-0094
Phase II Chemotherapy with CHIP in Patients with Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8512, NCI-T85-0126C, T85-0126
Phase II Single-Agent Chemotherapy with CHIP for Patients with Refractory Germ Cell Tumors (Summary Last Modified 02/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-8536A, NCI-T85-0103C, T85-0103
Start Over